(91 days)
Not Found
No
The description focuses on standard nerve conduction measurement technology and data transmission, with no mention of AI or ML algorithms for analysis or interpretation.
No
The device is described as a diagnostic tool used to measure neuromuscular signals to diagnose and evaluate neuropathies, not to treat them.
Yes.
The "Intended Use / Indications for Use" states that the device "is intended to measure neuromuscular signals that are useful in diagnosing and evaluating systemic and entrapment neuropathies." This explicit mention of "diagnosing" indicates its use as a diagnostic device.
No
The device description explicitly lists hardware components: a handheld monitor, a docking station, and disposable biosensors. While software is mentioned as part of the monitor, the device is not solely software.
Based on the provided information, the NeuroMetrix NC-stat is not an In Vitro Diagnostic (IVD) device.
Here's why:
- IVD Definition: In Vitro Diagnostics are devices intended for use in the collection, preparation, and examination of specimens taken from the human body (such as blood, urine, or tissue) to provide information for the diagnosis, monitoring, or treatment of disease.
- NC-stat Function: The NC-stat measures neuromuscular signals directly from the nerves in the body. It does not analyze specimens taken from the body. It is a device that interacts with the body to measure physiological signals.
Therefore, the NC-stat falls under the category of a neurological diagnostic device or a nerve conduction study device, but not an IVD.
N/A
Intended Use / Indications for Use
The NeuroMetrix NC-stat is intended to measure neuromuscular signals that are useful in diagnosing and evaluating systemic and entrapment neuropathies.
Product codes
JXE
Device Description
The NC-stat consists of the following four components:
- A handheld, battery-powered monitor. The monitor contains the electronic circuitry and software required to provide initiate and control the nerve conduction study, acquire and save patient and test information, display information on the LCD readout, and transmit data to the docking station. LCD displays include the distal motor latency (DML) value, the F-wave latency value, limb indicator (left or right), low battery indicator, the memory slot being used to store the test data, and user messages (menu selections, sensor serial numbers, device status, operator instructions, and error conditions).
- A docking station used to download the test data to the onCall Information Management Service via an analog phone line.
- Single-use, disposable biosensors for the median, ulnar, tibial, and peroneal nerves. The tibial and peroneal biosensors are the only new accessories for the NC-stat.
- The onCall Information Management Service for generation of the hardcopy patient test report, which includes test results (distal motor latency, F-wave latency, and associated waveforms) and a comparison of patient results to reference ranges. Reports are sent to the user by facsimile.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
neuromuscular signals (median, ulnar, tibial, and peroneal nerves); lower limb neuropathies
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Clinical data submitted in the 510(k) demonstrates that nerve conduction measurements obtained using the NC-stat are comparable to those obtained using conventional nerve conduction measurement equipment.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
K982359, K000565, K003508, K802637
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 882.1550 Nerve conduction velocity measurement device.
(a)
Identification. A nerve conduction velocity measurement device is a device which measures nerve conduction time by applying a stimulus, usually to a patient's peripheral nerve. This device includes the stimulator and the electronic processing equipment for measuring and displaying the nerve conduction time.(b)
Classification. Class II (performance standards).
0
K 013459
510(k) Summary for NC-stat
JAN 1 7 2002
1. SPONSOR
NeuroMetrix, Inc. 62 Fourth Avenue Waltham, MA 02451
Joseph Burke Contact Person: (781) 890-9989 Telephone:
October 17, 2001 Date Prepared:
2. DEVICE NAME
| Proprietary Name: | NC-stat |
|---|---|
| Common/Usual Name: | Nerve Conduction Monitoring System |
| Classification Name: | Nerve Conduction Velocity Measuring Device |
PREDICATE DEVICES 3.
INTENDED USE 4.
The NeuroMetrix NC-stat is intended to measure neuromuscular signals that are useful in diagnosing and evaluating systemic and entrapment neuropathies.
DEVICE DESCRIPTION ..
The NC-stat consists of the following four components:
- A handheld, battery-powered monitor. The monitor contains the electronic રે ત circuitry and software required to provide initiate and control the nerve conduction study, acquire and save patient and test information, display
1
information on the LCD readout, and transmit data to the docking station. LCD displays include the distal motor latency (DML) value, the F-wave latency value, limb indicator (left or right), low battery indicator, the memory slot being used to store the test data, and user messages (menu selections, sensor serial numbers, device status, operator instructions, and error conditions).
- A docking station used to download the test data to the onCall Information 5.2 Management Service via an analog phone line.
- Single-use, disposable biosensors for the median, ulnar, tibial, and peroneal ર.3 nerves. The tibial and peroneal biosensors are the only new accessories for the NC-stat.
- 5.4 The onCall Information Management Service for generation of the hardcopy patient test report, which includes test results (distal motor latency, F-wave latency, and associated waveforms) and a comparison of patient results to reference ranges. Reports are sent to the user by facsimile.
BASIS FOR SUBSTANTIAL EQUIVALENCE ર્.
The NC-stat that is the subject of this 510(k) Premarket Notification is substantially equivalent to the NC-stat as previously cleared for marketing and to the TECA TD-10/TD-20 EMG and nerve conduction velocity measurement device. The purpose of this 510(k) is to describe changes made to the NC-stat, including:
- Addition of the tibial and peroneal biosensors for use in diagnosing lower 6.1 limb neuropathies.
- 6.2 Engineering changes necessary to enable the NC-stat to be used for nerve conduction studies of the lower limbs.
- 6.3 Modifications to the labeling.
None of the changes to the NC-stat have altered the intended use of the device, the basic device design or the device operation. Clinical data submitted in the 510(k) demonstrates that nerve conduction measurements obtained using the NC-stat are comparable to those obtained using conventional nerve conduction measurement equipment.
2
Image /page/2/Picture/12 description: The image shows the seal of the Department of Health & Human Services (HHS) of the United States. The seal features the department's name encircling a symbol. The symbol consists of three stylized, interconnected shapes that resemble abstract human figures or flowing forms.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JAN 1 7 2002
NeuroMetrix, Inc. c/o Ms. Sheila Hemeon-Heyer, Esq. RAC Medical Device Consultants, Inc. 49 Plain Street North Attleboro, Massachusetts 02760
Re: K013459
Trade/Device Name: NC-stat Regulation Number: 882.1550 Regulation Name: Nerve conduction velocity measurement device Regulatory Class: JXE Product Code: II Dated: October 17, 2001 Received: October 18, 2001
Dear Ms. Hemeon-Heyer :
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
3
Page 2 - Ms. Sheila Hemeon-Heyer, Esq. RAC
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Mach N Millan
Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
510(k) Number (if known): 《 013459
Device Name: NC-stat
Indications for Use:
The NeuroMetrix NC-stat is intended to measure neuromuscular signals that are useful in diagnosing and evaluating systemic and entrapment neuropathies.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NECESSARY)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Mark N. Mellman
(Division Sign-Off) Division of General, Restorative and Neurological Devices
510(k) Number K013459
Prescription Use
(Per 21 CFR 801.109)
OR
Over-The-Counter Use _
(Optional Format 1-2-96)